Membership
Tour
Register
Log in
David DiLillo
Follow
Person
New York, NY, US
People
Overview
Industries
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof
Patent number
11,905,332
Issue date
Feb 20, 2024
REGENERON PHARMACEUTICALS, INC.
David DiLillo
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Compositions and methods for treating cancer
Patent number
11,826,386
Issue date
Nov 28, 2023
REGENERON PHARMACEUTICALS, INC.
David DiLillo
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
Patent number
11,384,153
Issue date
Jul 12, 2022
Regeneran Pharmaceuticals, Inc.
Eric Smith
C07 - ORGANIC CHEMISTRY
Patents Applications
last 30 patents
Information
Patent Application
COMPOSITIONS AND METHODS FOR TREATING CANCER
Publication number
20240165157
Publication date
May 23, 2024
Regeneron Pharmaceuticals, Inc.
David DiLillo
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF
Publication number
20240158529
Publication date
May 16, 2024
Regeneron Pharmaceuticals, Inc.
David DiLillo
C07 - ORGANIC CHEMISTRY
Information
Patent Application
METHODS OF TREATING CANCER WITH A COMBINATION OF ADOPTIVE CELL THER...
Publication number
20240148867
Publication date
May 9, 2024
Regeneron Pharmaceuticals, Inc.
David DiLillo
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
MULTISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND CD38 AND 4-1BB, A...
Publication number
20230416396
Publication date
Dec 28, 2023
Regeneron Pharmaceuticals, Inc.
Robert Babb
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof
Publication number
20220306758
Publication date
Sep 29, 2022
Regeneron Pharmaceuticals, Inc.
Eric Smith
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Chimeric Antigen Receptors with MAGE-A4 Specificity and Uses Thereof
Publication number
20220281994
Publication date
Sep 8, 2022
Regeneron Pharmaceuticals, Inc.
Kevin Bray
C07 - ORGANIC CHEMISTRY
Information
Patent Application
ANTI-NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 (NY-ESO-1) ANTIG...
Publication number
20220251215
Publication date
Aug 11, 2022
Regeneron Pharmaceuticals, Inc.
Kevin A. Bray
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF
Publication number
20220089766
Publication date
Mar 24, 2022
Regeneron Pharmaceuticals, Inc.
David DiLillo
C07 - ORGANIC CHEMISTRY
Information
Patent Application
COMPOSITIONS AND METHODS FOR TREATING CANCER
Publication number
20220031748
Publication date
Feb 3, 2022
Regeneron Pharmaceuticals, Inc.
David DiLillo
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Application
Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof
Publication number
20200024356
Publication date
Jan 23, 2020
Regeneron Pharmaceuticals, Inc.
Eric Smith
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof
Publication number
20200023010
Publication date
Jan 23, 2020
Regeneron Pharmaceuticals, Inc.
David DiLillo
C07 - ORGANIC CHEMISTRY